MedPath

Purdue University

Purdue University logo
🇺🇸United States
Ownership
Private
Established
1869-05-06
Employees
10K
Market Cap
-
Website
http://www.purdue.edu

Clinical Trials

164

Active:3
Completed:129

Trial Phases

4 Phases

Early Phase 1:2
Phase 1:9
Phase 4:2
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (147 trials with phase data)• Click on a phase to view related trials

Not Applicable
134 (91.2%)
Phase 1
9 (6.1%)
Early Phase 1
2 (1.4%)
Phase 4
2 (1.4%)

Retrieval-Based Word Learning in Developmental Language Disorder During Book Reading II

Not Applicable
Recruiting
Conditions
Developmental Language Disorder and Language Impairment
Specific Language Impairment
Language Development
First Posted Date
2025-07-02
Last Posted Date
2025-07-04
Lead Sponsor
Purdue University
Target Recruit Count
32
Registration Number
NCT07048392
Locations
🇺🇸

Purdue University, West Lafayette, Indiana, United States

Retrieval-based Word Learning in Developmental Language Disorder: Adaptive Retrieval Schedule

Not Applicable
Recruiting
Conditions
Developmental Language Disorder
Specific Language Impairment
Language Development
First Posted Date
2025-05-29
Last Posted Date
2025-06-03
Lead Sponsor
Purdue University
Target Recruit Count
32
Registration Number
NCT06995014
Locations
🇺🇸

Purdue University, West Lafayette, Indiana, United States

Impact of Soluble Arabinoxylan and Rice Bran Fiber on the Gut Microbiome in Healthy Adults

Not Applicable
Not yet recruiting
Conditions
Healthy
First Posted Date
2025-03-12
Last Posted Date
2025-06-29
Lead Sponsor
Purdue University
Target Recruit Count
25
Registration Number
NCT06873204
Locations
🇺🇸

Clinical Research Center at Purdue University, West Lafayette, Indiana, United States

How Does Perimenopausal Menorrhagia Affect Women's Quality of Life and Cognitive Function?

Not Applicable
Not yet recruiting
Conditions
Iron Deficiency Anemia Treatment
Iron Deficiency
Iron Deficiency (without Anemia)
First Posted Date
2025-01-29
Last Posted Date
2025-02-13
Lead Sponsor
Purdue University
Target Recruit Count
240
Registration Number
NCT06798584
Locations
🇺🇸

Stone Hall, West Lafayette, Indiana, United States

Wellness Intervention for Nurses Post Traumatic Growth and Selfcare

Not Applicable
Completed
Conditions
Trauma, Psychological
Moral Injury
Compassion Fatigue
First Posted Date
2024-11-05
Last Posted Date
2024-11-05
Lead Sponsor
Purdue University
Target Recruit Count
160
Registration Number
NCT06674876
Locations
🇺🇸

Purdue University, West Lafayette, Indiana, United States

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 33
  • Next

News

LyoWave Secures $300K NSF Grant to Scale Microwave-Enhanced Freeze-Drying Technology for Pharmaceutical Manufacturing

LyoWave Inc. received a $304,436 Phase I SBIR grant from the National Science Foundation to advance its high-frequency microwave heating technology for pharmaceutical lyophilization.

Eli Lilly and Purdue University Forge $250 Million Partnership to Accelerate Pharmaceutical Innovation

Eli Lilly and Purdue University have announced an expanded collaboration worth up to $250 million to advance pharmaceutical research and development across multiple therapeutic areas.

Eli Lilly Commits $250 Million to Expand Purdue University Research Alliance Through 2032

Eli Lilly has extended its research collaboration with Purdue University through 2032, investing up to $250 million over the next eight years in what could become the largest industry-academic partnership in the United States.

Lilly and Purdue University Forge Historic $250 Million Pharmaceutical Innovation Partnership

Eli Lilly and Purdue University have announced a landmark collaboration worth up to $250 million over eight years, potentially becoming the largest industry-academic agreement of its kind in the United States.

Eradivir Launches Phase 2 Human Challenge Study for Novel Influenza Therapeutic EV25

Eradivir has initiated a Phase 2 human challenge study for EV25, a novel antiviral therapeutic, following successful Phase 1 results showing the compound was well-tolerated in healthy participants.

Eli Lilly Invests $92.5M in Purdue University to Advance Pharmaceutical Manufacturing and Research

Eli Lilly commits $42.5M to establish a new pharmaceutical manufacturing scholarship program at Purdue University, supporting 75-100 students annually with full tuition and guaranteed internships.

© Copyright 2025. All Rights Reserved by MedPath